Should firms that finance the pot industry really be drug-testing employees?


There’s nothing like a growth industry to excite investors and financiers. Just look at the cannabis business, which is expected to generate hundreds of billions of dollars worldwide in the coming years and is already on a streak in the stock market. Financing companies that grow weed or make related products should be a no-brainer for banks. Yet doing so in the US is risky.

Ga naar Bron